{"name":"STORM Therapeutics LTD","slug":"storm-therapeutics-ltd","ticker":"","exchange":"","domain":"storm.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE4xMHVKU1RITHdrZjVaUW1md05BUnU3UzhLMG82YXJHUWtDYnpMTDFEU051UjVWVlFDLTcyb3dpQTZQcTVnempQbmM0ekhjeVBPVlp2NDJyMHl1QllIR3ZF?oc=5","date":"2026-01-13","type":"trial","source":"nature.com","summary":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson - nature.com","headline":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE84ajVyRloxSHRLYTVhUXMwbkVoYXR2WkdwTld4ZW5ZaGhfYTdvTXdXNzZoaWUyZEQzalJzSlJFajNiNlVWTlFYaXgtSVAxdl81N0ljQ05xbnRkQ3JvVHNBOGp2U2tfZThLSVVaOQ?oc=5","date":"2026-01-13","type":"pipeline","source":"pharmaphorum","summary":"JPM: The calm before the storm for radiotherapeutics - pharmaphorum","headline":"JPM: The calm before the storm for radiotherapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNVWxwX2VIZ2N3LU15NldpWmx6YW9DbExVVzEwSm1XUkxDYUN4aWhUb3dhcDhHWk1pQkJJTWEtVXdPeVRYNEcxRWVCTDBuakZHRDhhWHJtRElKSHZCVlZuUFFVWUVReDM5NHo0WlF4ZGkxcjB3dlk0UklLd0FKN01FbDUzUXBtTDFWMkhJSjA2b2tQQVBfV09yczA3Vk9ENC1jbk40aUdBX3NXYkdVQWxBbzhQMmFIbGZJbm1rS1ltbUFlQQ?oc=5","date":"2026-01-08","type":"deal","source":"pharmatimes.com","summary":"Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies - pharmatimes.com","headline":"Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNMW1HWGJMWlo5dEdhYUFIaUNGWHlvN1N6Vkp6ZUF5bm9NU2I5SENjM2tyZXRMS05aUm5RaXBiXzhGLUpHNURTZ19oZWF4WWdSb08xa1pWY01UdjAyX3U0ZXM0cm00MTRfUXVBRnJFVnlZNnEtRk9YVWRDaW14SlhvODVfZ2hGVlhVWDBQdjNsYjExZmRBQ2RWZ2F4dFhUcm9SRERpcUp5RQ?oc=5","date":"2025-12-23","type":"pipeline","source":"BioWorld News","summary":"Big pharma taps fast Asia innovation in search of next Keytruda - BioWorld News","headline":"Big pharma taps fast Asia innovation in search of next Keytruda","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQNWdSTjdiY2xSYm5ZN0NFaTZVMUdjei1kWnRDYTZUOFAtOWl6V0JTX3YxbnZ2dnE0N3pldFZLQ0xaMEVIbEtEVFdia3g5Uk5iRml3ZUV5elMyN3lzaEowR0Rmay1WWWFHZTdqZHg1dk9jNVdDVkk2MGU1SjAtTGVfaVliQmU5MFpBUldDbjVDVQ?oc=5","date":"2025-12-22","type":"pipeline","source":"The Motley Fool Australia","summary":"Telix shares storm higher on big US and China news - The Motley Fool Australia","headline":"Telix shares storm higher on big US and China news","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQSlRlbmZhcXRVYmZQTU9SNDFwR0RWMUJmMGxZcUZPRlVuT2hhYmY0Z2pFNXhIU1lNM2tZcHJfQ3F6bHNfMkc4MGJpbUZSX1QxdFlQdjFfeGZkQnVNcUhiYS04V1VNVXowSkhGY3hHdGQ3SkR0OGRlSWJ2STFDQjIxeUNLWWplUWw2c0RscHV1R3Ixa1dueF9DdjM3TURyaTBJ?oc=5","date":"2025-09-23","type":"pipeline","source":"politico.eu","summary":"Ireland’s ‘Viagra Village’ in the eye of Trump’s tariff storm - politico.eu","headline":"Ireland’s ‘Viagra Village’ in the eye of Trump’s tariff storm","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-08","type":"pipeline","source":"Business Standard","summary":"Pharma Inc mulls offshore strategy as US tariff fears hit sentiment - Business Standard","headline":"Pharma Inc mulls offshore strategy as US tariff fears hit sentiment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQMEhaNklOc0FIMVZoTFhpWm16QjRVMFAzck5TOGVJV04xQnozdl9UYmg1dFRuOGE4aTJFZWVWZHBUR0M2LVZFaV9GdUlib3d2aUZNdGhYeDltb0k0OEV5MVhfMHgyUGpXQnJONGJ4TFA1TnNKbFVHYWF0M3pvSXpHaGpB?oc=5","date":"2025-07-01","type":"pipeline","source":"pharmaphorum","summary":"Changing Faces – Pharma and biotech hires – May 2025 - pharmaphorum","headline":"Changing Faces – Pharma and biotech hires – May 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOMGFYMl9TXzZrMDdOd3dCaDk4bEZLeEZnTWVyVVhibVdZSVJESGM2WDh4SWdfWWNFb29udERqSzBkdnNteC1lZmpKRXd4Y1VwZVJ3d2xmQ0pKWmhUX0hKU1U4WDVQSXJTRmlDYnI4NDliQVNzbFh6cjVKcnhhSFhvaGIzc1ZYdXBxWFdyV2ZPbHpyaEF3?oc=5","date":"2025-05-28","type":"pipeline","source":"BioCentury","summary":"Southwell succeeds Hugh-Jones as CEO of Volastra - BioCentury","headline":"Southwell succeeds Hugh-Jones as CEO of Volastra","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTFBDM3VsM3F0TUxKY0haeVc0ZGVLLVY3bnZzaFhEdE5iMm40TFd0bTV2Umc1TFA2NjhDRTBybTFNVVdJNkZHb0VQVFdscTlPU2otSW15bGZFd1lBQldFNm9na2RVNy1BZw?oc=5","date":"2024-10-18","type":"pipeline","source":"University of Cambridge","summary":"10 Cambridge spinouts changing the story of cancer - University of Cambridge","headline":"10 Cambridge spinouts changing the story of cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNdEw5Z3VGYnpyZlVwbzlndkdYUXVBRnJYMDBReHJDbGJVRlNJb09EZ3pjbXB3NzBFbEtCR01LeFN1Y1R3czM4QUdkNGlNekM4VGJ6bDM5VjJKbUw4SzM2Y0ZCZlF2azRqSTV0VWltZnBzQW9Rck5xOC0wZ2EwdDJzQ2x2OWlra1g0WE5z?oc=5","date":"2022-09-06","type":"pipeline","source":"BioPharma Dive","summary":"Drugging RNA with pills: small molecules for a big frontier - BioPharma Dive","headline":"Drugging RNA with pills: small molecules for a big frontier","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxPZE5PMEFIbG53dkxHMTlHMnJJeExRWEpnZHBfX3pycDE2WWwxRk8yVEtfMmhmSjg5YVNHZmZYUl9KVmVSWFp1RlJaX1FncDdqY2ZEbG9vREdOSWxYWDBLaUZMbFdFUlRJTGRQQkNGamk5cTB4blZkZlUwUnJrY3pmT0xHNlg4OGxQYVpoTkNzRjRIMlNkajUyRUZlbkVuSkVkUnBRdGx0TEdaNmNpcWg3aUIxSGVrQjVQM3JPYlBsNWE1Q0l4Ni1fWWJKSkpiVkcydXVsQlNJT0daSWxrd25wZmd4RTBzWE95ZUN4VzNDX1A3UEFEb3d3WVdJdmNvd0ZQeWFkSWhTN3pRa25icmFfcFRsYS05UlRrTE5Ib2tRQ3d5bFpYMjVSNm5IZlY5SmxFdnBqZVR3?oc=5","date":"2021-10-14","type":"deal","source":"Business Wire","summary":"Exelixis and STORM Therapeutics Enter into Exclusive Collaboration and License Agreement to Discover and Develop Inhibitors of Novel RNA Modifying Enzymes - Business Wire","headline":"Exelixis and STORM Therapeutics Enter into Exclusive Collaboration and License Agreement to Discover and Develop Inhibit","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}